Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.18    -0.005 (-2.70%)
Bid:
0.17
Ask:
0.19
Spread: 0.02 (11.765%)
Market Cap: £1.34m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Interim Results

26 Sep 2006 16:46

Azure Holdings PLC26 September 2006 Azure Holdings Plc (" Company") Interim results for the six months ended 30 June 2006 Chairman's statement I am pleased to present the interim accounts for the six months ended 30 June2006. In the six months to 30 June 2006 the Company announced a loss after taxation of£138,000 (2005: £74,000). The figures should not reflect the future of the Company, which hopefully willmove forward successfully as ValiRx plc from early next month, because, asannounced on 11 September 2006, the reverse acquisition of ValiRx Limited hasbeen agreed and is subject to shareholders approval at the EGM scheduled for 2October 2006. If all the resolutions at that meeting are approved, the Company will retain itsAIM quotation and I will resign as Chairman leaving the new board and GerryDesler, Finance Director from the old board, to run the Company. Barry GoldChairman 26 September 2006 Azure Holdings plc Profit and Loss Account for the six months ended 30 June 2006 6 months ended 6 months ended Year ended 31 30 June 2006 30 June 2005 December 2005 (unaudited) (unaudited) (audited) £'000 £'000 £'000 Turnover - - - Administrative expenses (138) (74) (134) Operating loss (138) (74) (134) Loss on ordinary activities before taxation (138) (74) (134) Tax on loss on ordinary activities - - - Loss on ordinary activities after taxation (138) (74) (134) Retained loss for the period (138) (74) (134) Loss per ordinary share (0.12p) (0.15p) (0.28p) The profit and loss account has been prepared on the basis that all operationsare continuing operations. All recognised gains or losses are dealt withthrough the profit and loss account or statement of recognised gains and losses. Azure Holdings plc Balance Sheet as at 30 June 2006 30 June 2006 30 June 2005 31 December 2005 (unaudited) (unaudited) (audited) £'000 £'000 £'000Current assetsDebtors 9 3 1Cash at bank and in hand 127 1 1 136 4 2 Creditors: amounts falling due within one year (103) (147) (205) Net current assets/(liabilities) 33 (143) (203) Total assets less current liabilities 33 (143) (203) Net (liabilities)/assets 33 (143) (203) Capital and reservesCalled up Share Capital 6,271 5,475 5,475Share Premium 9,858 10,279 10,279Profit and loss account (16,096) (15,897) (15,957) Equity shareholders funds 33 (143) (203) Azure Holdings plc Cash Flow Statement for the six months ended 30 June 2006 6 months ended 6 months ended 30 June 2006 30 June 2005 (unaudited) (unaudited) £'000 £'000Net cash inflow (outflow) from operating activities (249) (13) FinancingIssue of ordinary shares 796 - Share premium reduction arising onconversion of loan stock (421) - Increase/(Decrease) in cash 126 (13) Azure Holdings plc Notes to the Interim Results 1. The interim results are unaudited and do not constitute statutoryaccounts within the meaning of section 240 of the Companies Act 1985. Thefigures for the year ended 31 December 2005 have been extracted from thestatutory accounts filed with the registrar of companies on which the auditorsgave an unqualified report. 2. The interim results have been prepared using the accountingpolicies set out in the statutory accounts for the year ended 31 December 2005. 3. The comparative figures for the unaudited interim results for theperiod ended 30 June 2005 are stated as announced on 27 September 2005. 4. Loss per share The loss per share for the six months ended 30 June 2006 has been calculated onthe basis of the loss after taxation for the period of £138,000 (2005: £74,000) and the weighted average number of shares in issue during the period of118,717,810 (2005: 48,317,569). . 5. The directors do not propose to pay a dividend for the period. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Jul 202210:46 amRNSHolding(s) in Company
13th Jul 20222:15 pmRNSSuccessful evaluation of breast cancer programme
7th Jul 202211:07 amRNSDirector/PDMR Shareholding
5th Jul 202211:45 amRNSHolding(s) in Company
5th Jul 20227:00 amRNSBroker Option Results
30th Jun 20223:00 pmRNSResult of AGM and Appointment of Joint Broker
30th Jun 202210:31 amRNSIssue of Equity
30th Jun 202210:30 amRNSExtends exclusivity period for TheoremRx
17th Jun 202210:01 amRNSUpdate on VAL201 sub-license agreement
7th Jun 20224:33 pmRNSAnnual Report, AGM Notice & Director Resignation
23rd Mar 20227:00 amRNSUpdate on proposed sub-license of VAL201
15th Mar 20227:00 amRNSOperational and Strategy Update
14th Feb 20227:00 amRNSEvaluation agreement with University of Barcelona
5th Jan 20224:41 pmRNSSecond Price Monitoring Extn
5th Jan 20224:36 pmRNSPrice Monitoring Extension
5th Jan 20222:06 pmRNSSecond Price Monitoring Extn
5th Jan 20222:00 pmRNSPrice Monitoring Extension
5th Jan 202211:00 amRNSPrice Monitoring Extension
5th Jan 20229:06 amRNSSecond Price Monitoring Extn
5th Jan 20229:00 amRNSPrice Monitoring Extension
5th Jan 20227:16 amRNSSigns Service Agreement with TheoremRx
20th Dec 20217:00 amRNSAmends License for VAL201 with CRT
16th Dec 202110:46 amRNSEvaluation agreement with Hokkaido University
11th Nov 20217:00 amRNSLive Shareholder Q&A and Investor presentations
8th Nov 20213:03 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSSigns Letter of Intent to Sub-License VAL201
26th Oct 20212:00 pmRNSPrice Monitoring Extension
26th Oct 202111:05 amRNSSecond Price Monitoring Extn
26th Oct 202111:00 amRNSPrice Monitoring Extension
26th Oct 20217:00 amRNSHolding(s) in Company
20th Oct 20211:19 pmRNSHolding(s) in Company
19th Oct 202112:23 pmRNSHolding(s) in Company
18th Oct 20214:41 pmRNSSecond Price Monitoring Extn
18th Oct 20214:36 pmRNSPrice Monitoring Extension
18th Oct 20212:06 pmRNSSecond Price Monitoring Extn
18th Oct 20212:01 pmRNSPrice Monitoring Extension
18th Oct 202111:06 amRNSSecond Price Monitoring Extn
18th Oct 202111:00 amRNSPrice Monitoring Extension
30th Sep 20212:45 pmRNSHolding(s) in Company
30th Sep 202112:24 pmRNSHolding(s) in Company
28th Sep 20214:41 pmRNSSecond Price Monitoring Extn
28th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 20214:41 pmRNSSecond Price Monitoring Extn
17th Sep 20214:36 pmRNSPrice Monitoring Extension
16th Sep 20217:00 amRNSNew Evaluation Agreement
8th Sep 20217:00 amRNSHolding(s) in Company
7th Sep 20217:00 amRNSHalf-year Report
25th Aug 20217:00 amRNSAppointment of Broker
20th Aug 20212:05 pmRNSSecond Price Monitoring Extn
20th Aug 20212:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.